investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

Ultragenyx Pharmaceutical Inc
(90400D108)

Funds Reporting Holdings of Ultragenyx Pharmaceutical Inc according to 13F filings
Firm Name Shares Held / Principal Amount Market Value Option Report Period Effectiveness Date
Rock Springs Capital Management LP 580,000 $36,830k Jun 30, 2019 Aug 14, 2019
Ecor1 Capital LLC 497,899 $31,617k Jun 30, 2019 Aug 14, 2019
Highline Capital Management LP 390,453 $24,794k Jun 30, 2019 Aug 14, 2019
First Light Asset Management LLC 180,017 $11,431k Jun 30, 2019 Aug 14, 2019
HOOD River Capital Management LLC 131,846 $8,372k Jun 30, 2019 Aug 13, 2019
Orbimed Advisors LLC 79,607 $5,055k Jun 30, 2019 Aug 14, 2019
Tekla Capital Management LLC 38,480 $2,443k Jun 30, 2019 Aug 14, 2019
Capital Impact Advisors LLC 36,165 $2,244k Jun 30, 2019 Jul 19, 2019
Point72 Asset Management LP 34,263 $2,176k Jun 30, 2019 Aug 14, 2019
QS Investors LLC 16,100 $1,023k Jun 30, 2019 Aug 14, 2019
Woodstock Corporation 11,212 $712k Jun 30, 2019 Jul 3, 2019
PIER 88 Investment Partners LLC 10,365 $658k Jun 30, 2019 Aug 8, 2019
Atika Capital Management LLC 10,033 $637k Jun 30, 2019 Aug 12, 2019
Pacific VIEW Asset Management LLC 6,216 $394k Jun 30, 2019 Aug 14, 2019

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.